These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 17931693
1. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter. Amini Nekoo A, Iles D. Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693 [Abstract] [Full Text] [Related]
4. Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level. Ishikawa J, Okada H, Kato H, Takeshita S, Honda S, Kawasaki T, Suehisa E, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Ikeda Y, Kokubo Y, Okamura T, Tomoike H, Miyata T. Blood Coagul Fibrinolysis; 2009 Jan; 20(1):22-6. PubMed ID: 20523161 [Abstract] [Full Text] [Related]
5. Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide. Liu W, Zhu ZQ, Wang W, Zu SY, Zhu GJ. Thromb Haemost; 2007 May; 97(5):839-46. PubMed ID: 17479196 [Abstract] [Full Text] [Related]
7. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels. Moatti D, Haidar B, Fumeron F, Gauci L, Boudvillain O, Seknadji P, Olliver V, Aumont MC, de Prost D. Thromb Haemost; 2000 Aug; 84(2):244-9. PubMed ID: 10959696 [Abstract] [Full Text] [Related]
12. C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimura H, Kawasaki T, Kato H. Thromb Haemost; 1998 Aug; 80(2):345-6. PubMed ID: 9716167 [No Abstract] [Full Text] [Related]
14. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Riazanskaia N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y, Nicolaou M, Farrer L, Bazan NG, Rogaev E. Mol Psychiatry; 2002 Aug; 7(8):891-8. PubMed ID: 12232783 [Abstract] [Full Text] [Related]
17. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability. Skretting G, Lien T, Sandset PM, Iversen N. Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969 [Abstract] [Full Text] [Related]
18. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Nadir Y, Brenner B, Gingis-Velitski S, Levy-Adam F, Ilan N, Zcharia E, Nadir E, Vlodavsky I. Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145 [Abstract] [Full Text] [Related]
19. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression. Schedel M, Frei R, Bieli C, Cameron L, Adamski J, Lauener R, Kabesch M. J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768 [Abstract] [Full Text] [Related]
20. No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity. Kereszturi E, Kiraly O, Barta C, Molnar N, Sasvari-Szekely M, Csapo Z. BMC Mol Biol; 2006 May 24; 7():18. PubMed ID: 16723017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]